GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes
Findings suggest future guidelines prioritise drugs with dual blood glucose and neuroprotective effects GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of its kind, published in ...

